A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease.
Giorgini, Flaviano
A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease. [electronic resource] - Nature genetics May 2005 - 526-31 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
1061-4036
10.1038/ng1542 doi
Autophagy--physiology
Humans
Huntington Disease--drug therapy
Kynurenine 3-Monooxygenase
Microglia--metabolism
Mixed Function Oxygenases--genetics
Mutation
Saccharomyces cerevisiae--enzymology
A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease. [electronic resource] - Nature genetics May 2005 - 526-31 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
1061-4036
10.1038/ng1542 doi
Autophagy--physiology
Humans
Huntington Disease--drug therapy
Kynurenine 3-Monooxygenase
Microglia--metabolism
Mixed Function Oxygenases--genetics
Mutation
Saccharomyces cerevisiae--enzymology